Investigation of BRCAness associated miRNA-gene axes in breast cancer: cell-free miR-182-5p as a potential expression signature of BRCAness
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Investigation of BRCAness associated miRNA-gene axes in breast cancer: cell-free miR-182-5p as a potential expression signature of BRCAness
Authors
Keywords
-
Journal
BMC CANCER
Volume 22, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-06-17
DOI
10.1186/s12885-022-09761-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PARPi, immunothérapies et anticorps monoclonaux conjugués dans les cancers du sein triple-négatifs
- (2021) Florence Dalenc et al. BULLETIN DU CANCER
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- An Overview of PARP Inhibitors for the Treatment of Breast Cancer
- (2021) Laura Cortesi et al. Targeted Oncology
- Immune checkpoint inhibitors: review of the existing evidence and challenges in breast cancer
- (2021) Mobina Jalalvand et al. Immunotherapy
- Circular RNA hsa_circ_0044234 as distinct molecular signature of triple negative breast cancer: a potential regulator of GATA3
- (2021) Farzaneh Darbeheshti et al. Cancer Cell International
- Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer
- (2021) Andrew N.J. Tutt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Using next‐generation sequencing to redefine BRCAness in triple‐negative breast cancer
- (2020) Po‐Han Lin et al. CANCER SCIENCE
- BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers
- (2020) Florence Coussy et al. Science Translational Medicine
- Regulation of DNA Damage Response and Homologous Recombination Repair by microRNA in Human Cells Exposed to Ionizing Radiation
- (2020) Magdalena Szatkowska et al. Cancers
- MiRNA and LncRNA as Potential Biomarkers in Triple-Negative Breast Cancer: A Review
- (2020) Simona Ruxandra Volovat et al. Frontiers in Oncology
- PARP Inhibitors as a Therapeutic Agent for Homologous Recombination Deficiency in Breast Cancers
- (2019) Man Keung et al. Journal of Clinical Medicine
- Homologous recombination deficiency in triple negative breast cancer
- (2019) Carmen Belli et al. BREAST
- Induction of BRCAness in Triple-Negative Breast Cancer by a CDK12/13 Inhibitor Improves Chemotherapy
- (2019) Jessica L. Hopkins et al. CANCER CELL
- miR-146a promoted breast cancer proliferation and invasion by regulating NM23-H1
- (2019) Jun Chen et al. JOURNAL OF BIOCHEMISTRY
- Rare BRIP1 Missense Alleles Confer Risk for Ovarian and Breast Cancer
- (2019) Cassandra L. Moyer et al. CANCER RESEARCH
- Cell-free microRNAs as Non-invasive Diagnostic and Prognostic Biomarkers in Pancreatic Cancer
- (2019) Natalia A. Gablo et al. CURRENT GENOMICS
- Novel prognostic and predictive microRNA targets for triple-negative breast cancer
- (2018) Gulisa Turashvili et al. FASEB JOURNAL
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- Regulation of DNA Double-Strand Break Repair by Non-Coding RNAs
- (2018) Roopa Thapar MOLECULES
- Mechanisms of PARP inhibitor resistance in cancer and insights into the DNA damage response
- (2018) Paola Francica et al. Genome Medicine
- Dysregulation of microRNAs in triple-negative breast cancer
- (2017) Sylwia Paszek et al. Ginekologia Polska
- HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures
- (2017) Helen Davies et al. NATURE MEDICINE
- Pan-cancer analysis of bi-allelic alterations in homologous recombination DNA repair genes
- (2017) Nadeem Riaz et al. Nature Communications
- Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer
- (2017) Fergus J. Couch et al. JAMA Oncology
- miR-146a and miR-638 in BRCA1-deficient triple negative breast cancer tumors, as potential biomarkers for improved overall survival
- (2016) Valentina Zavala et al. Cancer Biomarkers
- Relationship of immunohistochemistry, copy number aberrations and epigenetic disorders with BRCAness pattern in hereditary and sporadic breast cancer
- (2016) Rosa Murria Estal et al. Familial Cancer
- miR-151-5p, targeting chromatin remodeler SMARCA5, as a marker for the BRCAness phenotype
- (2016) Stefania Tommasi et al. Oncotarget
- MicroRNA deregulation in triple negative breast cancer reveals a role of miR-498 in regulating BRCA1 expression
- (2016) Nerea Matamala et al. Oncotarget
- Post-transcriptional Regulation of BRCA2 through Interactions with miR-19a and miR-19b
- (2016) Elena Mogilyansky et al. Frontiers in Genetics
- BRCAness as a Biomarker for Predicting Prognosis and Response to Anthracycline-Based Adjuvant Chemotherapy for Patients with Triple-Negative Breast Cancer
- (2016) Hitomi Mori et al. PLoS One
- Multigene Panel Testing Detects Equal Rates of Pathogenic BRCA1/2 Mutations and has a Higher Diagnostic Yield Compared to Limited BRCA1/2 Analysis Alone in Patients at Risk for Hereditary Breast Cancer
- (2015) Nimmi S. Kapoor et al. ANNALS OF SURGICAL ONCOLOGY
- Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment
- (2015) Andrea Desmond et al. JAMA Oncology
- Association of microRNAs and pathologic response to preoperative chemotherapy in triple negative breast cancer: preliminary report
- (2014) Agnieszka Kolacinska et al. MOLECULAR BIOLOGY REPORTS
- MicroRNAs Expression in Triple Negative vs Non Triple Negative Breast Cancer in Tunisia: Interaction with Clinical Outcome
- (2014) Imen Medimegh et al. PLoS One
- MicroRNAs down-regulate homologous recombination in the G1 phase of cycling cells to maintain genomic stability
- (2014) Young Eun Choi et al. eLife
- MicroRNAs in the DNA Damage/Repair Network and Cancer
- (2014) Alessandra Tessitore et al. International Journal of Genomics
- Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers
- (2013) E H Lips et al. BRITISH JOURNAL OF CANCER
- Mapping the Human miRNA Interactome by CLASH Reveals Frequent Noncanonical Binding
- (2013) Aleksandra Helwak et al. CELL
- Selecting housekeeping genes as references for the normalization of quantitative PCR data in breast cancer
- (2013) Y. Kılıç et al. Clinical & Translational Oncology
- Hereditary Breast Cancer: The Era of New Susceptibility Genes
- (2013) Paraskevi Apostolou et al. Biomed Research International
- MicroRNAs and DNA damage response
- (2012) Yemin Wang et al. CELL CYCLE
- The Majority of MicroRNAs Detectable in Serum and Saliva Is Concentrated in Exosomes
- (2012) Alessia Gallo et al. PLoS One
- MicroRNA-182-5p targets a network of genes involved in DNA repair
- (2012) K. Krishnan et al. RNA
- Down-regulation ofBRCA1expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers
- (2011) Amandine I. Garcia et al. EMBO Molecular Medicine
- miR-182-Mediated Downregulation of BRCA1 Impacts DNA Repair and Sensitivity to PARP Inhibitors
- (2010) Patryk Moskwa et al. MOLECULAR CELL
- Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene
- (2010) Alfons Meindl et al. NATURE GENETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started